298 related articles for article (PubMed ID: 21426880)
1. C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival.
Haas M
Clin Nephrol; 2011 Apr; 75(4):271-8. PubMed ID: 21426880
[TBL] [Abstract][Full Text] [Related]
2. Pathology of C4d-negative antibody-mediated rejection in renal allografts.
Haas M
Curr Opin Organ Transplant; 2013 Jun; 18(3):319-26. PubMed ID: 23283250
[TBL] [Abstract][Full Text] [Related]
3. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
[TBL] [Abstract][Full Text] [Related]
4. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection.
Regele H; Böhmig GA; Habicht A; Gollowitzer D; Schillinger M; Rockenschaub S; Watschinger B; Kerjaschki D; Exner M
J Am Soc Nephrol; 2002 Sep; 13(9):2371-80. PubMed ID: 12191982
[TBL] [Abstract][Full Text] [Related]
5. The impact of C4d staining as a humoral injury marker.
Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
[TBL] [Abstract][Full Text] [Related]
6. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
[TBL] [Abstract][Full Text] [Related]
7. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
[TBL] [Abstract][Full Text] [Related]
8. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
9. C4d staining of perioperative renal transplant biopsies.
Haas M; Ratner LE; Montgomery RA
Transplantation; 2002 Sep; 74(5):711-7. PubMed ID: 12352891
[TBL] [Abstract][Full Text] [Related]
10. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
[TBL] [Abstract][Full Text] [Related]
11. Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum.
Haas M
Curr Opin Nephrol Hypertens; 2012 May; 21(3):264-71. PubMed ID: 22388553
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
13. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
14. The significance of C4d staining with minimal histologic abnormalities.
Haas M
Curr Opin Organ Transplant; 2010 Feb; 15(1):21-7. PubMed ID: 19907328
[TBL] [Abstract][Full Text] [Related]
15. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection.
Torres IB; Salcedo M; Moreso F; Sellarés J; Castellá E; Azancot MA; Perelló M; Cantarell C; Serón D
Clin Transplant; 2014 Oct; 28(10):1148-54. PubMed ID: 25103874
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated rejection in the liver allograft.
Hübscher SG
Curr Opin Organ Transplant; 2012 Jun; 17(3):280-6. PubMed ID: 22569512
[TBL] [Abstract][Full Text] [Related]
17. C4d-positive chronic rejection: a frequent entity with a poor outcome.
David-Neto E; Prado E; Beutel A; Ventura CG; Siqueira SA; Hung J; Lemos FB; de Souza NA; Nahas WC; Ianhez LE; David DR
Transplantation; 2007 Dec; 84(11):1391-8. PubMed ID: 18091514
[TBL] [Abstract][Full Text] [Related]
18. C4d deposition in early renal allograft protocol biopsies.
Koo DD; Roberts IS; Quiroga I; Procter J; Barnardo MC; Sutton M; Cerundolo L; Davies DR; Friend PJ; Morris PJ; Fuggle SV
Transplantation; 2004 Aug; 78(3):398-403. PubMed ID: 15316368
[TBL] [Abstract][Full Text] [Related]
19. The importance of C4d in biopsies of kidney transplant recipients.
Corrêa RR; Machado JR; da Silva MV; Helmo FR; Guimarães CS; Rocha LP; Faleiros AC; dos Reis MA
Clin Dev Immunol; 2013; 2013():678180. PubMed ID: 23935649
[TBL] [Abstract][Full Text] [Related]
20. Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.
Choi J; Cho YM; Yang WS; Park TJ; Chang JW; Park SK
Clin Transplant; 2007; 21(2):159-65. PubMed ID: 17425739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
